Latest Interviews
Showing 8866–8880 of 9,624 transcripts.
Clear all filters- Goldman Sachs9 min
Mrs. Laura Bush - A Conversation on Empowering Women in Afghanistan: Talks at GS Session Highlights
Laura Bush, Mrs. Laura Bush, Manizha Naderi, Mrs. Bush, Manisha
Former First Lady Laura Bush launched her book *We Are Afghan Women*, which chronicles the struggles and resilience of 29 Afghan women alongside activist Manisha, who details the founding of a shelter network now serving over 21,000 survivors. The work highlights how marginalized women like Manisha transformed decades of conflict into progress, establishing educational systems and advocacy groups while noting that the nation's reconstruction may take another forty years. Bush emphasizes that female civic participation is a prerequisite for national stability, drawing parallels to the 1920 U.S. suffrage movement to advocate for patient, long-term investment in Afghan women's rights.
- Goldman Sachs11 min
Shaquille O’Neal: Talks at GS Session Highlights
Shaquille O’Neal, Tanya Cushman Reviewer, Peter van de Ven
LSU basketball alum and scholar Peter van de Ven, who transitioned from a struggling teen athlete to a doctorate holder in organizational leadership, discusses his unique philosophy of blending humor and seriousness to drive community revitalization in Newark. Through his "Impact Newark" initiative, van de Ven is working with local officials to prevent resident displacement by establishing apprenticeship programs that keep residents employed in their home city. His presentation also details personal anecdotes ranging from his recruitment by Coach Brown and a humorous 50% free-throw success rate to being distracted by Halle Berry during a professional game.
- The Economist12 min
Body Builders: the science and technology of bionic limbs
Hilda Einersdottir, Gummy, David Johnson, Farmer David Ingvason, Gunner
Iceland is emerging as the global hub for the bionics industry, where companies like Ossur are deploying brain-controlled prosthetics that translate subconscious neural signals into intuitive movement. Pioneering trials with users ranging from farmers to 92-year-olds have validated the technology's ability to restore mobility in high-stress and aging populations, with the Power Knee offering rotational force comparable to a motorcycle. Driven by medical necessity and a market projected to exceed $20 billion within five years, engineers anticipate a major leap in capabilities over the next decade toward fully autonomous thought-driven systems.
- Goldman Sachs15 min
Jamie Redford: Talks at GS Session Highlights
Jamie Redford launched his documentary *Resilience* at the Sundance Film Festival to expose the biological and societal impacts of adverse childhood experiences, a project developed alongside *Paper Tigers* to showcase a compassionate school model that significantly improved graduation rates and reduced violence. Driven by his family's history with organ donation and dyslexia, Redford utilizes the Redford Center's collaborative framework to produce purpose-driven films that link toxic stress to chronic disease and criminal behavior. These efforts align with the Sundance Institute's continued mission to amplify underrepresented global voices, ensuring diverse narratives reach audiences while demonstrating how stable adult relationships can alter life trajectories for traumatized youth.
- Milken Institute14 min
Mike Milken │ Public Health and Prosperity
Historical shifts in medical research funding and technological advancements have reduced genome sequencing costs to approximately $1,000 while driving significant economic growth through improved public health. A modern summit now unites government agencies, pharmaceutical entities, and insurers to address the trillion-dollar burden of lifestyle-related diseases by prioritizing prevention, accelerating translational science, and fostering public-private partnerships. This collective strategy aims to fundamentally transform the treatment of life-threatening conditions through innovations like cancer vaccines and immunology drugs within the next few years.
- Milken Institute45 min
Carrots, Sticks and Nudges: Balancing Public Health and Personal Freedom
Megan McArdle, David Boaz, Bob Casey, Doug Teitelbaum
A bipartisan panel led by Senators Casey and Burr convened to address critical gaps in pandemic preparedness, stagnant antibiotic innovation, and the evolving definition of public health beyond infectious diseases. Experts highlighted systemic failures ranging from the erosion of scientific trust and bureaucratic barriers to bariatric surgery to the market disincentives preventing new antibiotic development and the regulatory controversies surrounding e-cigarettes. Ultimately, the discussion emphasized that future progress requires a "multiplier effect" of collaboration between government and private sectors, coupled with greater empathy for individuals struggling with chronic conditions to bridge the divide between public health policy and patient reality.
- Milken Institute1h 18m
Public Health, Medical Research and the Cancer Moonshot: A Collaboration to Change the World
Michael Milken, Francis Collins, Linda Fried, Robert Hugin, Freda Lewis-Hall
Vice President Biden and medical leaders are launching a strategic "Cancer Moonshot" to overcome siloed research through a $680 million federal investment and the Precision Medicine Initiative's enrollment of one million Americans. The framework prioritizes seven key themes, including early detection blood tests, single-cell analysis, and public-private partnerships modeled after the Accelerating Medicines Partnership, while explicitly warning against overpromising a timeline for a universal cure. Parallel to the National Institutes of Health and FDA funding, the initiative integrates public health science to address prevention drivers and leverages global data collaboration to accelerate the shift toward data-driven, individualized cancer therapies.
- Milken Institute1h 26m
Public Health Summit Dinner March 2, 2016
Mike Milken, Tom Frieden, Rob Califf, Fred Upton, Nancy Pelosi, Francis Collins
This event featured key figures including Francis Collins, FDA Commissioner Rob Califf, and CDC Director Tom Frieden discussing critical public health challenges such as the implementation gap between knowledge and action, rising opioid overdose deaths, and the threat of a post-antibiotic era. The proceedings highlighted specific policy responses ranging from Mexico's successful food taxes and "health stops" to the U.S. House passing the 21st Century Cures Act and funding the Brain Initiative, alongside clinical breakthroughs in treating depression and heart failure. To address these systemic issues, officials urged for robust funding, the adoption of global "find, stop, prevent" strategies, and a massive volunteer effort for the Precision Medicine Initiative to accelerate biomedical discovery.
- Goldman Sachs15 min
Kelly Holmes: Talks at GS Session Highlights
Kelly Holmes, Dame Kelly Holmes
Dame Kelly Holmes recounts her journey from a self-proclaimed clumsy student in Kent to a British Army Physical Training Instructor who defied a male-dominated military structure to become an elite athlete. After overcoming a decade of severe injuries, a depression diagnosis, and a strategic decision to prioritize the 1500m, she achieved the historic Olympic double by winning gold in both the 800m and 1500m at the 2004 Athens Games. Her narrative emphasizes how military discipline and resilience enabled her to conquer athletic setbacks and fulfill a childhood dream sparked by watching Sebastian Coe in 1984.
- Milken Institute55 min
The Promise of Public Health
Mike Klowden, Richard Besser, Nancy Brown, Thomas Farley, Joseph Jimenez, Fred Upton
The Milken Institute's inaugural Public Health Summit convened key industry and government leaders, including Novartis CEO Joe Jimenez, CDC Director Tom Frieden, and Congressman Fred Upton, to advocate for elevating disease prevention alongside medical cures. Participants analyzed critical strategies such as conditional reimbursement models, real-time data utilization, and the "21st Century Cures Act" to address looming challenges posed by an aging global population and stagnant biotech venture capital. The consensus emphasized that sustainable health outcomes require shifting from volume-based treatment to outcome-based policies that integrate genomics, behavioral interventions, and bipartisan legislative support to bridge significant disparities in US public health metrics.
- Milken Institute21 min
Atul Butte | Driving Public Health: A Trillion Points of Data
Addressing the exponential growth of biomedical data, the presentation details UCSF's initiative to consolidate electronic records from 14.1 million patients into a unified warehouse that shifts disease tracking from code-based to molecular-based systems. This infrastructure enables low-cost computational predictions, such as the rapid repurposing of imipramine for lung cancer, which accelerated a clinical trial from concept to authorization within fifteen months. By creating dynamic maps of patient disease progression, the project aims to redefine accountable care through continuous, population-level monitoring rather than isolated clinical encounters.
- Milken Institute51 min
Infectious Diseases: Staying One Step Ahead
Michael Gerson, Michael Kurilla, Vanina Laurent-Ledru, Pranav Shetty, Moncef Slaoui
Experts including Vanina Laurent Ledru of Sanofi Pasteur and Monsef Slaoui of GSK advocate shifting global health strategy from reactive outbreak response to proactive prevention to counter drivers like climate change and increased mobility. Leveraging platform technologies and industrial-scale manufacturing, the industry aims to bypass the traditional decade-long vaccine development cycle for threats such as Ebola, Zika, and pandemic flu while addressing critical gaps in local infrastructure and surveillance. Despite improvements in specific regions, the panel concludes that long-term consistency in funding and international cooperation is essential to prevent future crises from overwhelming fragile health systems.
- Milken Institute46 min
A Future of Healthy Aging
Paul Irving, Pinchas Cohen, Linda Fried, Freda Lewis-Hall, Robin Mockenhaupt
A global panel convened to address the critical misalignment between rising life expectancy and stagnant healthspan, framing older adults as an underutilized human capital asset essential for the 21st-century economy. The discussion highlighted that delaying Alzheimer's onset by five years could halve annual caregiving costs and proposed a "Frieden's Triangle" strategy combining genomic risk assessment, social engagement programs, and targeted public health policies to transform prevention. To realize this vision, the group advocated for a "third demographic dividend" through a tenfold increase in federal funding, clinical trial reforms for geriatric populations, and the creation of new social institutions designed specifically for the emerging thirty-year life stage.
- Milken Institute54 min
The Health of Nations: Meeting the Sustainable Development Goals
Matthew Bishop, David Barash, Stefano Bertozzi, Deborah Birx, Jacqueline Shea
A panel of global health experts and industry leaders convened to evaluate the gap between current Social Progress Index trajectories and the ambitious targets set by the UN Sustainable Development Goals. The discussion highlighted critical failures in data granularity, vaccine development funding, and the unique health crises facing high-income nations like the United States. Experts concluded that achieving these goals requires a strategic pivot from charity-based models to shared-value ecosystems driven by granular data, impact investing, and cross-sector innovation.
- Milken Institute16 min
Barbara Bush | Resilience in Global Health Leadership
Founded in 2009 by Barbara Bush and five peers, Global Health Corps addresses global health leadership gaps by competitively selecting and training diverse millennial fellows through a specialized curriculum developed with Yale and Harvard. The organization has placed 600 young leaders into 70 partner organizations across Africa and the United States, resulting in a 97% sector retention rate and measurable policy impacts among alumni. By focusing on systems change and resilience, Global Health Corps aims to cultivate a new generation of executives who will fundamentally restructure healthcare delivery to ensure universal access within two decades.